Primary cutaneous leiomyosarcoma: a clinicopathological and immunohistochemical study of 7 cases. 2004

Guido Bellezza, and Angelo Sidoni, and Antonio Cavaliere, and Massimo Scheibel, and Emilio Bucciarelli
Institute of Pathological Anatomy and Histology, Division of Cancer Research, Perugia University, Italy.

Primary cutaneous leiomyosarcomas are rare tumors, few series being reported in the current literature. A retrospective study of 7 cases was undertaken to understand the clinicopathological characteristics of these neoplasms and some of their molecular mutations. Histologically, a well-differentiated proliferation of cells of smooth muscle derivation was evident in all cases. The number of mitoses was considered the most important criterion of malignancy (more than 2 for 10 HPF). Smooth muscle actin, desmin, and vimentin were positive in all cases. Immunohistochemical analysis also revealed a positivity for p53 in 3 cases and no reaction for retinoblastoma protein. Research for Epstein-Barr virus was negative in all cases. Three patients developed local recurrences owing to incomplete surgical excision. Recurrent tumors were more atypical and located deeper. No distant metastases were observed. Our results emphasize that cutaneous leiomyosarcomas have an indolent biological course if treated by surgical excision with wide margins. Molecular abnormalities involving tumor suppressor genes are probably involved.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D007890 Leiomyosarcoma A sarcoma containing large spindle cells of smooth muscle. Although it rarely occurs in soft tissue, it is common in the viscera. It is the most common soft tissue sarcoma of the gastrointestinal tract and uterus. The median age of patients is 60 years. (From Dorland, 27th ed; Holland et al., Cancer Medicine, 3d ed, p1865) Leiomyosarcoma, Epithelioid,Leiomyosarcoma, Myxoid,Epithelioid Leiomyosarcoma,Epithelioid Leiomyosarcomas,Leiomyosarcomas,Leiomyosarcomas, Epithelioid,Leiomyosarcomas, Myxoid,Myxoid Leiomyosarcoma,Myxoid Leiomyosarcomas
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective

Related Publications

Guido Bellezza, and Angelo Sidoni, and Antonio Cavaliere, and Massimo Scheibel, and Emilio Bucciarelli
December 2007, Pathologica,
Guido Bellezza, and Angelo Sidoni, and Antonio Cavaliere, and Massimo Scheibel, and Emilio Bucciarelli
January 2010, Histopathology,
Guido Bellezza, and Angelo Sidoni, and Antonio Cavaliere, and Massimo Scheibel, and Emilio Bucciarelli
June 1988, Journal of cutaneous pathology,
Guido Bellezza, and Angelo Sidoni, and Antonio Cavaliere, and Massimo Scheibel, and Emilio Bucciarelli
October 1996, Journal of cutaneous pathology,
Guido Bellezza, and Angelo Sidoni, and Antonio Cavaliere, and Massimo Scheibel, and Emilio Bucciarelli
January 2021, Indian journal of pathology & microbiology,
Guido Bellezza, and Angelo Sidoni, and Antonio Cavaliere, and Massimo Scheibel, and Emilio Bucciarelli
April 2004, Annales de pathologie,
Guido Bellezza, and Angelo Sidoni, and Antonio Cavaliere, and Massimo Scheibel, and Emilio Bucciarelli
June 2008, Human pathology,
Guido Bellezza, and Angelo Sidoni, and Antonio Cavaliere, and Massimo Scheibel, and Emilio Bucciarelli
January 2017, Human pathology,
Guido Bellezza, and Angelo Sidoni, and Antonio Cavaliere, and Massimo Scheibel, and Emilio Bucciarelli
February 2012, Journal of cutaneous pathology,
Guido Bellezza, and Angelo Sidoni, and Antonio Cavaliere, and Massimo Scheibel, and Emilio Bucciarelli
January 2007, Polish journal of pathology : official journal of the Polish Society of Pathologists,
Copied contents to your clipboard!